Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40000 participants
OBSERVATIONAL
2011-01-01
2048-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Colorectal Cancer Database
NCT05434026
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382
Sigmoid Take-off, New Rectum Definition
NCT04293835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
colorectal cancer
Colorectal cancer patients are enrolled when patients were underwent surgeries.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Visit our center with complete medical records and pathological information;
* 3\. Colorectal cancer patients diagnosed between 2013 and 2023.
Exclusion Criteria
* 2\. Malignant tumors adjacent to organs invading the colon and rectum;
* 3\. Malignant tumors from distant organs metastasize to the colon and rectum;
* 4\. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fourth Military Medical University
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jipeng Li
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Cao S, Qiao Y, Wu L, Chen Q, Tian K, Li J, Xing C. Postoperative adjuvant chemotherapy in patients with stage II early onset colorectal cancer: exploration and discovery using real-world data and the SEER database. Front Oncol. 2025 May 30;15:1566569. doi: 10.3389/fonc.2025.1566569. eCollection 2025.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRC dataset
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.